Wegovy and Zepbound Emerge as Leading Choices in New Obesity Treatment Guidelines

Healthcare experts are changing the way they approach obesity treatment. New clinical guidelines recommend Wegovy (semaglutide) and Zepbound (tirzepatide) as the preferred first-line medications for people living with obesity and […]